Feb 26 (Reuters) - FibroGen Inc said on Monday it is regaining rights to the anemia drug, roxadustat, from AstraZeneca after the companies mutually agreed to terminate their collaboration agreement. (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
The $50 million purchase could turn into Nvidia's biggest investment.
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
SHANGHAI (Reuters) -Tesla CEO Elon Musk arrived in Beijing on Sunday for a surprise visit, where he is expected to meet senior officials to discuss the rollout of Full Self-Driving software and permission to transfer data overseas, according to a person with knowledge of the matter. The U.S. electric vehicle maker rolled out Full Self-Driving, or FSD, the most autonomous version of its Autopilot software, four years ago but has yet to make it available in China, its second-largest market globally, despite customers urging it to do so. Musk said this month Tesla may make FSD available to customers in China "very soon", in response to a query on social media platform X.
The tobacco giant will soon be allowed to sell a proven product in a proven market.
(Bloomberg) -- Jerome Powell’s remarks in the coming week will be closely parsed by investors for any clues on just how long the Federal Reserve is willing to wait before cutting interest rates.Most Read from BloombergBHP’s $39 Billion Copper Play Was Years in the MakingFed Repricing Gives Rise to New Equities Playbook in AsiaApple Intensifies Talks With OpenAI for iPhone Generative AI FeaturesThe Long, Slow Death of Urban NightlifePlunging Home Prices, Fleeing Companies: Austin’s Glow Is Fading